287 related articles for article (PubMed ID: 17928647)
1. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
[TBL] [Abstract][Full Text] [Related]
2. Aliskiren inhibits experimental venous thrombosis in two-kidney one- clip hypertensive rats.
Hermanowicz JM; Hermanowicz A; Buczko P; Leszczynska A; Tankiewicz-Kwedlo A; Mogielnicki A; Buczko W
Thromb Res; 2013 Jan; 131(1):e39-44. PubMed ID: 23174623
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
[TBL] [Abstract][Full Text] [Related]
4. 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2/prostacyclin pathway.
Chlopicki S; Swies J; Mogielnicki A; Buczko W; Bartus M; Lomnicka M; Adamus J; Gebicki J
Br J Pharmacol; 2007 Sep; 152(2):230-9. PubMed ID: 17641676
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.
Kramkowski K; Leszczynska A; Mogielnicki A; Chlopicki S; Fedorowicz A; Grochal E; Mann B; Brzoska T; Urano T; Motterlini R; Buczko W
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2149-57. PubMed ID: 22772756
[TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits arterial thrombosis through endothelial cell protection and stimulation of prostacyclin.
Hu H; Zhang XX; Wang YY; Chen SZ
Acta Pharmacol Sin; 2005 Sep; 26(9):1063-8. PubMed ID: 16115372
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II via AT1 receptor accelerates arterial thrombosis in renovascular hypertensive rats.
Kamińska M; Mogielnicki A; Stankiewicz A; Kramkowski K; Domaniewski T; Buczko W; Chabielska E
J Physiol Pharmacol; 2005 Dec; 56(4):571-85. PubMed ID: 16391415
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide and its metabolite N-methylnicotinamide increase skin vascular permeability in rats.
Pietrzak L; Mogielnicki A; Buczko W
Clin Exp Dermatol; 2009 Apr; 34(3):380-4. PubMed ID: 19175785
[TBL] [Abstract][Full Text] [Related]
9. Thiol repletion prevents venous thrombosis in rats by nitric oxide/prostacyclin-dependent mechanism: relation to the antithrombotic action of captopril.
Pawlak R; Chabielska E; Matys T; Kucharewicz I; Rółkowski R; Buczko W
J Cardiovasc Pharmacol; 2000 Oct; 36(4):503-9. PubMed ID: 11026653
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
Wojewódzka-Zelezniakowicz M; Chabielska E; Mogielnicki A; Kramkowski K; Karp A; Opadczuk A; Domaniewski T; Malinowska-Zaprzałka M; Buczko W
J Physiol Pharmacol; 2006 Jun; 57(2):231-45. PubMed ID: 16845228
[TBL] [Abstract][Full Text] [Related]
11. Repeat oral dosing of prasugrel, a novel P2Y12 receptor inhibitor, results in cumulative and potent antiplatelet and antithrombotic activity in several animal species.
Niitsu Y; Sugidachi A; Ogawa T; Jakubowski JA; Hashimoto M; Isobe T; Otsuguro K; Asai F
Eur J Pharmacol; 2008 Jan; 579(1-3):276-82. PubMed ID: 17996866
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of nimodipine on platelet aggregation and thrombosis.
Ren YJ; Lü AG; Zhang GQ; Jia DH
Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):158-60. PubMed ID: 10374642
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II enhances thrombosis development in renovascular hypertensive rats.
Mogielnicki A; Chabielska E; Pawlak R; Szemraj J; Buczko W
Thromb Haemost; 2005 Jun; 93(6):1069-76. PubMed ID: 15968390
[TBL] [Abstract][Full Text] [Related]
14. [Effect of phenolic alkaloids of Menispermum dauricum on thrombosis and platelet aggregation].
Kong XY; Gong PL
Yao Xue Xue Bao; 2005 Oct; 40(10):916-9. PubMed ID: 16408809
[TBL] [Abstract][Full Text] [Related]
15. Thrombolytic activity of beta-adrenolytic drug, sotalol.
Korbut R; Swies J; Marcinkiewicz E; Gryglewski RJ
J Physiol Pharmacol; 1998 Mar; 49(1):51-60. PubMed ID: 9594410
[TBL] [Abstract][Full Text] [Related]
16. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
[TBL] [Abstract][Full Text] [Related]
17. [Effects of neferine and its combination with taurine on platelet aggregation and experimental thrombosis in rats].
Huang HL; Rao MR
Yao Xue Xue Bao; 1995; 30(7):486-90. PubMed ID: 7484155
[TBL] [Abstract][Full Text] [Related]
18. Comparison of antiplatelet effects of two nitric oxide-donating agents, FR146801 and FK409.
Hirasawa Y; Kato Y; Fukuyama S; Ohno M; Nishino S; Kato M; Kita Y
Thromb Haemost; 1998 Mar; 79(3):620-4. PubMed ID: 9531052
[TBL] [Abstract][Full Text] [Related]
19. Modifications produced by indomethacin and L-NAME in the effect of ultralow-dose aspirin on platelet activity in portal hypertension.
Eizayaga FX; Aguejouf O; Desplat V; Belon P; Doutremepuich C
Pathophysiol Haemost Thromb; 2006; 35(5):357-63. PubMed ID: 17230036
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp).
Xiong J; Fang W; Fang W; Bai L; Huo J; Kong Y; Yunman L
J Pharm Pharmacol; 2009 Jan; 61(1):89-94. PubMed ID: 19126301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
